FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108754089> ?p ?o ?g. }

• W2108754089 endingPage "1625" @default.
• W2108754089 startingPage "1618" @default.
• W2108754089 abstract "In an observational study of 13 women with polycystic ovary syndrome (PCOS) not optimally responsive to metformin diet, we assessed the efficacy and safety of addition of pioglitazone. We also compared these 13 women to 26 women with PCOS, who were responsive to metformin diet, matched by age and by pre- treatment menstrual history and not different by obesity categories.Prospectively, as outpatients, with diet constant [1500-2000 calorie (depending on entry body mass index), 26% protein, 44% carbohydrate, 30% fat], metformin (2.55 g/day) was given for 12 months to 39 women, 13 not optimally responsive, 26 responsive to metformin diet, followed by addition of pioglitazone (45 mg/day) for 10 months in the 13 non-responders. Outcome measures included changes in sex hormones, insulin, insulin resistance (IR), insulin secretion, high density lipoprotein cholesterol, weight, and menstrual status.In 13 non-responders, on metformin diet, median serum insulin fell (21 to 16 microIU/ml, P<0.05) and insulin secretion fell from 251 to 200 (P<0.01); weight, dehydroepiandrosterone sulphate (DHEAS), testosterone and IR were unchanged (P> or =0.07). Compared with 14% pre- treatment, on metformin diet, expected menses occurred 46% of the time at 3 months (P=0.05), 38% at 6 months (P=0.07), 27% at 9 months, and 24% at 12 months. In 26 responders, on metformin diet, median weight fell (93 to 87 kg), testosterone fell (50 to 32 ng/dl), insulin fell (26 to 16 microIU/ml), IR fell (5.32 to 3.45) and insulin secretion fell (351 to 271) (P< or =0.017 for all). The occurrence of expected menses in the 26 responders was 2.5-fold higher than in the 13 non-responders (P<0.0001). In 11 non-responders, on pioglitazone + metformin diet over 10 months versus antecedent metformin diet, DHEAS fell (211 to 171 microg/dl, P=0.02), insulin fell (16 to 10 microIU/ml, P= 0.001), IR fell (3.37 to 1.73, P=0.002), insulin secretion fell (217 to 124, P=0.004), sex hormone-binding globulin rose (31 to 43 nmol/l, P=0.006), and HDL cholesterol rose (38 to 42 mg/dl, P=0.003). On pioglitazone + metformin diet, the occurrence of expected menses was 2-fold higher than on metformin diet (P<0.0001).In women with PCOS who failed to respond optimally to metformin, when pioglitazone was added, insulin, glucose, IR, insulin secretion, and DHEAS fell, HDL cholesterol and sex hormone-binding globulin rose, and menstrual regularity improved, without adverse side-effects." @default.
• W2108754089 created "2016-06-24" @default.
• W2108754089 creator A5079058910 @default.
• W2108754089 date "2003-08-01" @default.
• W2108754089 modified "2023-10-09" @default.
• W2108754089 title "Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin" @default.
• W2108754089 cites W120815510 @default.
• W2108754089 cites W1486665559 @default.
• W2108754089 cites W1965318069 @default.
• W2108754089 cites W1966243777 @default.
• W2108754089 cites W1970309796 @default.
• W2108754089 cites W1973495657 @default.
• W2108754089 cites W1975593644 @default.
• W2108754089 cites W1985157643 @default.
• W2108754089 cites W1996384706 @default.
• W2108754089 cites W1996445345 @default.
• W2108754089 cites W2010760524 @default.
• W2108754089 cites W2019937567 @default.
• W2108754089 cites W2022468713 @default.
• W2108754089 cites W2024109963 @default.
• W2108754089 cites W2044970382 @default.
• W2108754089 cites W2051770308 @default.
• W2108754089 cites W2052245273 @default.
• W2108754089 cites W2061950292 @default.
• W2108754089 cites W2067532199 @default.
• W2108754089 cites W2069655704 @default.
• W2108754089 cites W2070732543 @default.
• W2108754089 cites W2072474124 @default.
• W2108754089 cites W2074892672 @default.
• W2108754089 cites W2080744024 @default.
• W2108754089 cites W2081877349 @default.
• W2108754089 cites W2109769642 @default.
• W2108754089 cites W2124760769 @default.
• W2108754089 cites W2132594773 @default.
• W2108754089 cites W2140604643 @default.
• W2108754089 cites W2141428775 @default.
• W2108754089 cites W2144174136 @default.
• W2108754089 cites W2149183746 @default.
• W2108754089 cites W2159852002 @default.
• W2108754089 cites W2282948130 @default.
• W2108754089 cites W2324024668 @default.
• W2108754089 cites W2335922553 @default.
• W2108754089 cites W2408770126 @default.
• W2108754089 cites W2423365100 @default.
• W2108754089 cites W2916596946 @default.
• W2108754089 cites W3212023210 @default.
• W2108754089 cites W90218097 @default.
• W2108754089 cites W2187784433 @default.
• W2108754089 doi "https://doi.org/10.1093/humrep/deg343" @default.
• W2108754089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12871871" @default.
• W2108754089 hasPublicationYear "2003" @default.
• W2108754089 type Work @default.
• W2108754089 sameAs 2108754089 @default.
• W2108754089 citedByCount "100" @default.
• W2108754089 countsByYear W21087540892012 @default.
• W2108754089 countsByYear W21087540892013 @default.
• W2108754089 countsByYear W21087540892014 @default.
• W2108754089 countsByYear W21087540892015 @default.
• W2108754089 countsByYear W21087540892016 @default.
• W2108754089 countsByYear W21087540892018 @default.
• W2108754089 countsByYear W21087540892019 @default.
• W2108754089 countsByYear W21087540892020 @default.
• W2108754089 countsByYear W21087540892021 @default.
• W2108754089 countsByYear W21087540892022 @default.
• W2108754089 crossrefType "journal-article" @default.
• W2108754089 hasAuthorship W2108754089A5079058910 @default.
• W2108754089 hasConcept C126322002 @default.
• W2108754089 hasConcept C134018914 @default.
• W2108754089 hasConcept C2777180221 @default.
• W2108754089 hasConcept C2777391703 @default.
• W2108754089 hasConcept C2778384471 @default.
• W2108754089 hasConcept C2779306644 @default.
• W2108754089 hasConcept C2780323712 @default.
• W2108754089 hasConcept C3018442814 @default.
• W2108754089 hasConcept C555293320 @default.
• W2108754089 hasConcept C71924100 @default.
• W2108754089 hasConceptScore W2108754089C126322002 @default.
• W2108754089 hasConceptScore W2108754089C134018914 @default.
• W2108754089 hasConceptScore W2108754089C2777180221 @default.
• W2108754089 hasConceptScore W2108754089C2777391703 @default.
• W2108754089 hasConceptScore W2108754089C2778384471 @default.
• W2108754089 hasConceptScore W2108754089C2779306644 @default.
• W2108754089 hasConceptScore W2108754089C2780323712 @default.
• W2108754089 hasConceptScore W2108754089C3018442814 @default.
• W2108754089 hasConceptScore W2108754089C555293320 @default.
• W2108754089 hasConceptScore W2108754089C71924100 @default.
• W2108754089 hasIssue "8" @default.
• W2108754089 hasLocation W21087540891 @default.
• W2108754089 hasLocation W21087540892 @default.
• W2108754089 hasOpenAccess W2108754089 @default.
• W2108754089 hasPrimaryLocation W21087540891 @default.
• W2108754089 hasRelatedWork W138803513 @default.
• W2108754089 hasRelatedWork W1835582227 @default.
• W2108754089 hasRelatedWork W1986132654 @default.
• W2108754089 hasRelatedWork W1998227193 @default.
• W2108754089 hasRelatedWork W2010140898 @default.
• W2108754089 hasRelatedWork W2045340999 @default.
• W2108754089 hasRelatedWork W2082140668 @default.

• next